*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| D701 - Agranulocytosis secondary to cancer chemotherapy - as a primary diagnosis code | D701 - Agranulocytosis secondary to cancer chemotherapy - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 7.15 | |
| Readmission Rate (%) | 30.43 | |
| Unplanned Readmission Rate (%) | 16.98 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 810: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 977: HIV WITH OR WITHOUT OTHER RELATED CONDITION | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 45,432 | ||||
| Total Hospitalizations with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 7,053 | ||||
| DRG Share of Total Hospitalizations | 0.14 | ||||
| % of Total ICD D701 - Agranulocytosis secondary to cancer chemotherapy in DRG | 64.24 | ||||
| Avg LOS at DRG | 4.42 | ||||
| Avg LOS with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 4.43 | ||||
| Readmission Rate at DRG | 30.74 | ||||
| Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 28.26 | ||||
| Unplanned Readmission Rate at DRG | 18.94 | ||||
| Unplanned Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 16.59 | ||||
| Total Medicare payments at DRG | $376,347,273 | ||||
| Total Medicare payments with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $55,212,024 | ||||
| Total Medicare payment per Day at DRG | $1,873 | ||||
| Total Medicare payment per Day with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $1,765 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,284 | ||||
| Total Medicare payment per Hospitalization with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $7,828 | ||||
| Total Medicare Charges at DRG | $1,794,383,177 | ||||
| Total Medicare Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $243,505,376 | ||||
| Avg Charges at DRG | $39,496 | ||||
| Avg Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $34,525 | ||||
| Mortality Rate at DRG | 0.61 | ||||
| Mortality Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 0.54 | ||||
| SNF Discharge Rate at DRG | 7.48 | ||||
| SNF Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 5.46 | ||||
| Home Discharge Rate at DRG | 67.79 | ||||
| Home Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 72.44 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 802: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 803: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 2,892 | ||||
| Total Hospitalizations with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 31 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD D701 - Agranulocytosis secondary to cancer chemotherapy in DRG | 0.28 | ||||
| Avg LOS at DRG | 10.0 | ||||
| Avg LOS with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 13.97 | ||||
| Readmission Rate at DRG | 36.51 | ||||
| Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 53.33 | ||||
| Unplanned Readmission Rate at DRG | 23.86 | ||||
| Unplanned Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | NA | ||||
| Total Medicare payments at DRG | $71,327,019 | ||||
| Total Medicare payments with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $794,198 | ||||
| Total Medicare payment per Day at DRG | $2,466 | ||||
| Total Medicare payment per Day with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $1,834 | ||||
| Total Medicare payment per Hospitalization at DRG | $24,664 | ||||
| Total Medicare payment per Hospitalization with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $25,619 | ||||
| Total Medicare Charges at DRG | $318,373,644 | ||||
| Total Medicare Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $3,791,515 | ||||
| Avg Charges at DRG | $110,088 | ||||
| Avg Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $122,307 | ||||
| Mortality Rate at DRG | 5.08 | ||||
| Mortality Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | NA | ||||
| SNF Discharge Rate at DRG | 27.21 | ||||
| SNF Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | NA | ||||
| Home Discharge Rate at DRG | 32.95 | ||||
| Home Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 90 |
| SANFORD HEALTH | 801 BROADWAY N | FARGO | ND | 58122 | 51 |
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 48 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. THAHIR FARZAN | 1300 WALLACE BLVD | AMARILLO | TX | 79106 | 16 |
| Dr. LOUIS H GEERAERTS | 820 4TH ST N | FARGO | ND | 58122 | 14 |
| Dr. AMANDEEP KAUR DHATT | 200 CARMAN AVE | EAST MEADOW | NY | 11554 | 11 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 45,432 | ||||
| Total Hospitalizations with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 7,672 | ||||
| DRG Share of Total Hospitalizations | 0.14 | ||||
| % of Total ICD D701 - Agranulocytosis secondary to cancer chemotherapy in DRG | 16.96 | ||||
| Avg LOS at DRG | 4.42 | ||||
| Avg LOS with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 4.46 | ||||
| Readmission Rate at DRG | 30.74 | ||||
| Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 28.42 | ||||
| Unplanned Readmission Rate at DRG | 18.94 | ||||
| Unplanned Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 16.81 | ||||
| Total Medicare payments at DRG | $376,347,273 | ||||
| Total Medicare payments with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $60,112,432 | ||||
| Total Medicare payment per Day at DRG | $1,873 | ||||
| Total Medicare payment per Day with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $1,755 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,284 | ||||
| Total Medicare payment per Hospitalization with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $7,835 | ||||
| Total Medicare Charges at DRG | $1,794,383,177 | ||||
| Total Medicare Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $268,558,499 | ||||
| Avg Charges at DRG | $39,496 | ||||
| Avg Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $35,005 | ||||
| Mortality Rate at DRG | 0.61 | ||||
| Mortality Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 0.53 | ||||
| SNF Discharge Rate at DRG | 7.48 | ||||
| SNF Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 5.41 | ||||
| Home Discharge Rate at DRG | 67.79 | ||||
| Home Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 72.09 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 810: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 522,791 | ||||
| Total Hospitalizations with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 915 | ||||
| DRG Share of Total Hospitalizations | 1.59 | ||||
| % of Total ICD D701 - Agranulocytosis secondary to cancer chemotherapy in DRG | 2.02 | ||||
| Avg LOS at DRG | 3.14 | ||||
| Avg LOS with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 4.29 | ||||
| Readmission Rate at DRG | 17.1 | ||||
| Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 26.07 | ||||
| Unplanned Readmission Rate at DRG | 12.62 | ||||
| Unplanned Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 17.72 | ||||
| Total Medicare payments at DRG | $2,290,151,156 | ||||
| Total Medicare payments with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $4,636,760 | ||||
| Total Medicare payment per Day at DRG | $1,394 | ||||
| Total Medicare payment per Day with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $1,181 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,381 | ||||
| Total Medicare payment per Hospitalization with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $5,067 | ||||
| Total Medicare Charges at DRG | $13,619,287,561 | ||||
| Total Medicare Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $28,350,491 | ||||
| Avg Charges at DRG | $26,051 | ||||
| Avg Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $30,984 | ||||
| Mortality Rate at DRG | 0.18 | ||||
| Mortality Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | NA | ||||
| SNF Discharge Rate at DRG | 8.57 | ||||
| SNF Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 3.83 | ||||
| Home Discharge Rate at DRG | 72.49 | ||||
| Home Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 72.79 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 130,303 | ||||
| Total Hospitalizations with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 537 | ||||
| DRG Share of Total Hospitalizations | 0.4 | ||||
| % of Total ICD D701 - Agranulocytosis secondary to cancer chemotherapy in DRG | 1.19 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 4.77 | ||||
| Readmission Rate at DRG | 20.31 | ||||
| Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 25.29 | ||||
| Unplanned Readmission Rate at DRG | 14.61 | ||||
| Unplanned Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 17.7 | ||||
| Total Medicare payments at DRG | $778,992,768 | ||||
| Total Medicare payments with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $3,425,093 | ||||
| Total Medicare payment per Day at DRG | $1,517 | ||||
| Total Medicare payment per Day with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $1,337 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,978 | ||||
| Total Medicare payment per Hospitalization with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $6,378 | ||||
| Total Medicare Charges at DRG | $4,222,655,144 | ||||
| Total Medicare Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $18,873,573 | ||||
| Avg Charges at DRG | $32,406 | ||||
| Avg Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $35,146 | ||||
| Mortality Rate at DRG | 0.93 | ||||
| Mortality Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | NA | ||||
| SNF Discharge Rate at DRG | 14.17 | ||||
| SNF Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 6.15 | ||||
| Home Discharge Rate at DRG | 60.3 | ||||
| Home Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 67.23 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 365,119 | ||||
| Total Hospitalizations with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 409 | ||||
| DRG Share of Total Hospitalizations | 1.11 | ||||
| % of Total ICD D701 - Agranulocytosis secondary to cancer chemotherapy in DRG | 0.9 | ||||
| Avg LOS at DRG | 5.91 | ||||
| Avg LOS with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 7.96 | ||||
| Readmission Rate at DRG | 27.73 | ||||
| Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 28.94 | ||||
| Unplanned Readmission Rate at DRG | 20.3 | ||||
| Unplanned Readmission Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 20.34 | ||||
| Total Medicare payments at DRG | $3,552,910,533 | ||||
| Total Medicare payments with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $4,779,156 | ||||
| Total Medicare payment per Day at DRG | $1,646 | ||||
| Total Medicare payment per Day with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $1,467 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,731 | ||||
| Total Medicare payment per Hospitalization with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $11,685 | ||||
| Total Medicare Charges at DRG | $16,860,985,198 | ||||
| Total Medicare Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $27,176,262 | ||||
| Avg Charges at DRG | $46,179 | ||||
| Avg Charges with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | $66,446 | ||||
| Mortality Rate at DRG | 5.06 | ||||
| Mortality Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 11.0 | ||||
| SNF Discharge Rate at DRG | 28.7 | ||||
| SNF Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 14.67 | ||||
| Home Discharge Rate at DRG | 32.16 | ||||
| Home Discharge Rate with ICD D701 - Agranulocytosis secondary to cancer chemotherapy | 34.96 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| SANFORD HEALTH | 801 BROADWAY N | FARGO | ND | 58122 | 256 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 220 |
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 194 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MICHAEL PATTEN CARROLL | 1020 29TH ST | SACRAMENTO | CA | 95816 | 31 |
| Dr. SATINDERJIT S OBEROI | 902 N RIVERSIDE RD | SAINT JOSEPH | MO | 64507 | 19 |
| Dr. LOUIS H GEERAERTS | 820 4TH ST N | FARGO | ND | 58122 | 16 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SATINDERJIT S OBEROI | 902 N RIVERSIDE RD | SAINT JOSEPH | MO | 64507 | 60 |
| Dr. AMANDEEP KAUR DHATT | 200 CARMAN AVE | EAST MEADOW | NY | 11554 | 56 |
| Dr. LOUIS H GEERAERTS | 820 4TH ST N | FARGO | ND | 58122 | 51 |